Clinical comparative trial of co-artemether and benflumetol (two formulations) in the treatment of falciparum malaria
Clinical comparative trial of co-artemether and benflumetol (two formulations) in the treatment of falciparum malaria
Sun ZhiWei; Shan ChengQi; L.G.oFu; Ding DeBen; Liu GuangYu; Wang JingYan; Jiao XiuQing
Chinese Journal of Parasitology and Parasitic Diseases 18(3): 159-161
2000
ISSN/ISBN: 1000-7423
To observe the efficacy and safety of co-artemether and one of its components benflumetol (two formulations) in the treatment of patients with falciparum malaria. Using double-blind, randomization and comparative methods, all patients were hospitalized and observed for 28 days after treatment. Of 150 patients, 51 were treated with co-artemether (group A), 50 were treated with benflumetol tablets (group B), and 49 were treated with benflumetol capsules (group C).